ArticleActa neuropathologica2022

Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer's disease and Down syndrome.

Yvonne Bouter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.